{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:23:10Z","timestamp":1765610590538,"version":"3.45.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05664-7","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:04:53Z","timestamp":1763463893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Linezolid-associated severe hyperlactatemia masked by metabolic alkalosis in a geriatric patient: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Zhiyong","family":"Fei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunye","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"4","key":"5664_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nrneph.2010.20","volume":"6","author":"JC Velez","year":"2010","unstructured":"Velez JC, Janech MG. A case of lactic acidosis induced by linezolid. Nat Rev Nephrol. 2010;6(4):236\u201342.","journal-title":"Nat Rev Nephrol"},{"key":"5664_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","volume":"138","author":"RC Moellering","year":"2003","unstructured":"Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138:135\u201342.","journal-title":"Ann Intern Med"},{"issue":"2","key":"5664_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0897190018782787","volume":"33","author":"PE Tobias","year":"2020","unstructured":"Tobias PE, Varughese CA, Hanson AP, Gurnani PK. A case of linezolid induced toxicity. J Pharm Pract. 2020;33(2):222\u20135.","journal-title":"J Pharm Pract"},{"issue":"5","key":"5664_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/antibiotics10050530","volume":"10","author":"H Thirot","year":"2021","unstructured":"Thirot H, Briquet C, Frippiat F, Jacobs F, Holemans X, Henrard S, et\u00a0al. Clinical use and adverse drug reactions of linezolid: a retrospective study in four Belgian hospital centers. Antibiotics (Basel). 2021;10(5):530.","journal-title":"Antibiotics (Basel)"},{"key":"5664_CR5","doi-asserted-by":"publisher","first-page":"1555955","DOI":"10.3389\/fphar.2025.1555955","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Dai H, Chen X, Huang J, Miao F, Lv J, et\u00a0al. Risk of medication-induced lactic acidosis and hyperlactatemia: a pharmacovigilance study of the United States Food and Drug Administration\u2019s Adverse Event Reporting System Database. Front Pharmacol. 2025;16:1555955.","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"5664_CR6","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijtb.2023.04.006","volume":"71","author":"G Mishra","year":"2024","unstructured":"Mishra G, Alffenaar JW, Munje R, Khateeb S. Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: a retrospective multicenter study. Indian J Tuberc. 2024;71(Suppl 1):S101\u20139.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"5664_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12879-017-2499-1","volume":"17","author":"A Swaminathan","year":"2017","unstructured":"Swaminathan A, du Cros P, Seddon JA, Mirgayosieva S, Asladdin R, Dusmatova Z. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature. BMC Infect Dis. 2017;17(1):417.","journal-title":"BMC Infect Dis"},{"key":"5664_CR8","doi-asserted-by":"publisher","first-page":"1338902","DOI":"10.3389\/fphar.2024.1338902","volume":"15","author":"F Zou","year":"2024","unstructured":"Zou F, Cui Z, Lou S, Ou Y, Zhu C, Shu C, et\u00a0al. Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. Front Pharmacol. 2024;15:1338902.","journal-title":"Front Pharmacol"},{"issue":"1 Pt 2","key":"5664_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jfma.2020.06.011","volume":"120","author":"CN Cheng","year":"2021","unstructured":"Cheng CN, Wu CC, Kuo CH, Wang CC, Wang JT, Lin YT, et\u00a0al. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- Therapeutic drug monitoring in improving adverse drug reactions. J Formos Med Assoc. 2021;120(1 Pt 2):466\u201375.","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"5664_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/jcpt.13245","volume":"45","author":"Y Dai","year":"2020","unstructured":"Dai Y, Wang Y, Zeng Y, Zhang C, Zhou Z, Shi D. Linezolid and the risk of lactic acidosis: data mining and analysis of the FDA adverse event reporting system. J Clin Pharm Ther. 2020;45(6):1422\u20136.","journal-title":"J Clin Pharm Ther"},{"key":"5664_CR11","doi-asserted-by":"publisher","first-page":"2012798","DOI":"10.1155\/2017\/2012798","volume":"2017","author":"OC Moreira","year":"2017","unstructured":"Moreira OC, Est\u00e9banez B, Mart\u00ednez-Florez S, de Paz JA, Cuevas MJ, Gonz\u00e1lez-Gallego J. Mitochondrial function and mitophagy in the elderly: effects of exercise. Oxid Med Cell Longev. 2017;2017:2012798.","journal-title":"Oxid Med Cell Longev"},{"issue":"7877","key":"5664_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0140-6736(74)91784-X","volume":"2","author":"RD Cohen","year":"1974","unstructured":"Cohen RD, Woods HF, Alberti KG. Letter: lactic acidosis and hyperlactataemia. Lancet. 1974;2(7877):405.","journal-title":"Lancet"},{"issue":"8","key":"5664_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/15563650.2017.1317348","volume":"55","author":"E Blohm","year":"2017","unstructured":"Blohm E, Lai J, Neavyn M. Drug-induced hyperlactatemia. Clin Toxicol (Phila). 2017;55(8):869\u201378.","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"5664_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS De Vriese","year":"2006","unstructured":"De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, et\u00a0al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006;42(8):1111\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5664_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01599-17","volume":"62","author":"TV Milosevic","year":"2018","unstructured":"Milosevic TV, Payen VL, Sonveaux P, Muccioli GG, Tulkens PM, Van Bambeke F. Mitochondrial alterations (inhibition of mitochondrial protein expression, oxidative metabolism, and ultrastructure) induced by linezolid and tedizolid at clinically relevant concentrations in cultured human HL-60 promyelocytes and THP-1 monocytes. Antimicrob Agents Chemother. 2018;62(3): e01599\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"5664_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3128270","volume":"2018","author":"X Ye","year":"2018","unstructured":"Ye X, Huang A, Wang X, Wen C, Hu L, Lin G. Linezolid inhibited synthesis of ATP in mitochondria: based on GC-MS metabolomics and HPLC method. BioMed Res Int. 2018;2018: 3128270.","journal-title":"BioMed Res Int"},{"key":"5664_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.967311","volume":"10","author":"B Lin","year":"2022","unstructured":"Lin B, Hu Y, Xu P, Xu T, Chen C, He L, et\u00a0al. Expert consensus statement on therapeutic drug monitoring and individualization of linezolid. Front Public Health. 2022;10: 967311.","journal-title":"Front Public Health"},{"key":"5664_CR18","doi-asserted-by":"publisher","first-page":"1073407","DOI":"10.3389\/fphys.2023.1073407","volume":"14","author":"C Thomas","year":"2023","unstructured":"Thomas C, Peyrethon RD, Lambert K, Granata C, Hobbs T, Hanon C, Bishop DJ. The effect of pre-exercise alkalosis on lactate\/pH regulation and mitochondrial respiration following sprint-interval exercise in humans. Front Physiol. 2023;14:1073407.","journal-title":"Front Physiol"},{"issue":"1","key":"5664_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2215\/CJN.04500422","volume":"18","author":"A Achanti","year":"2023","unstructured":"Achanti A, Szerlip HM. Acid-base disorders in the critically ill patient. Clin J Am Soc Nephrol. 2023;18(1):102\u201312.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5664_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035245","volume":"7","author":"C Terzano","year":"2012","unstructured":"Terzano C, Di Stefano F, Conti V, Di Nicola M, Paone G, Petroianni A, Ricci A. Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation. PLoS ONE. 2012;7(4): e35245.","journal-title":"PLoS ONE"},{"issue":"9","key":"5664_CR21","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.annfar.2013.06.003","volume":"32","author":"P Esnault","year":"2013","unstructured":"Esnault P, Cotte J, Cungi PJ, Romanat PE, Boret H. Linezolid-induced hyperlactatemia in a burn patient. Ann Fr Anesth Reanim. 2013;32(9):e117\u20138.","journal-title":"Ann Fr Anesth Reanim"},{"issue":"3","key":"5664_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1128\/AAC.01190-06","volume":"51","author":"G Garrabou","year":"2007","unstructured":"Garrabou G, Soriano A, L\u00f3pez S, Guallar JP, Giralt M, Villarroya F, et\u00a0al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother. 2007;51(3):962\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5664_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s15010-007-6302-x","volume":"35","author":"M Wiener","year":"2007","unstructured":"Wiener M, Guo Y, Patel G, Fries BC. Lactic acidosis after treatment with linezolid. Infection. 2007;35(4):278\u201381.","journal-title":"Infection"},{"issue":"2","key":"5664_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/MJT.0000000000001337","volume":"30","author":"M Ghandour","year":"2023","unstructured":"Ghandour M, Alkassis S, Bhat ZY. Linezolid-induced lactic acidosis. Am J Ther. 2023;30(2):175\u20138.","journal-title":"Am J Ther"},{"issue":"2","key":"5664_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-259335","volume":"17","author":"V Ramesh","year":"2024","unstructured":"Ramesh V, Gattu S, Maqsood M, Rao V. Linezolid-induced lactic acidosis. BMJ Case Rep. 2024;17(2): e259335.","journal-title":"BMJ Case Rep"},{"issue":"8","key":"5664_CR26","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/jac\/dkae188","volume":"79","author":"T Liu","year":"2024","unstructured":"Liu T, Yuan Y, Wang C, Wu J, Wang Y, Na P, et\u00a0al. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study. J Antimicrob Chemother. 2024;79(8):1938\u201350.","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:05:03Z","timestamp":1763507103000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05664-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. As a case report, this paper did not require any referral to our institutional clinical ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent for this patient was provided by the patient's next-of-kin (the patient's daughter) for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"588"}}